.jpeg)
What are the common adverse reactions of Lebrikizumab?
Injection site reaction: This is a relatively common adverse reaction. Patients may experience pain, redness, swelling, itching, and induration at the injection site. Just like the local skin is irritated after an injection, the drug accumulates at the injection site and triggers an immune response, leading to inflammatory changes in local tissues. However, these symptoms are usually mild and usually resolve on their own within a few days to a week.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
